DocGo (Nasdaq: DCGO) has announced a partnership with Spect to enhance eye and vision health services. This collaboration allows DocGo's mobile health clinicians to use Spect's hand-held retinal cameras, providing scalable, cost-effective diabetic retinopathy and other eye disease screenings at patients' homes and workplaces.
This initiative aims to improve patient care and health plan quality ratings by integrating these screenings into DocGo's services. Spect's platform, known for its ease of use and minimal training requirements, can identify various eye diseases, including glaucoma and macular degeneration. The partnership focuses on supporting DocGo's health plan partnership offerings and addressing care gaps through in-home medical visits.